NR3C2 and Insulin resistance: Moreover, mineralocorticoid receptor blockade in adipose tissue reduces obesity‐related insulin resistance by decreasing oxidative stress and inflammatory macrophage infiltration, yet these local improvements may be masked when evaluating systemic insulin sensitivity using ITT or GTT.51